EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Spectrum and Prevalence of Rare APOE Variants and Their Association with Familial Dysbetalipoproteinemia

Anastasia V Blokhina iD, Alexandra I Ershova, Anna V Kiseleva iD, Evgeniia A Sotnikova, Anastasia A Zharikova iD, Marija Zaicenoka iD, Yuri V Vyatkin, Vasily E Ramensky iD, Vladimir A Kutsenko, Elizaveta V Garbuzova iD, Mikhail G Divashuk iD, Olga A Litinskaya iD und 4 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252312651 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Anastasia V Blokhina und 15 weiteren Autor:innen. Beteiligte Einrichtung: National Medical Research Center for Therapy and Preventive Medicine, Ministry of Healthcare of the Russian Federation, Petroverigsky per. 10, Bld. 3…. Hauptthemen laut MEDLINE: Apolipoproteins E. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Familial dysbetalipoproteinemia (FD) is a highly atherogenic, prevalent genetically based lipid disorder. About 10% of FD patients have rare APOE variants associated with autosomal dominant FD. However, there are insufficient data on the relationship between rare APOE variants and FD. Genetic data from 4720 subjects were used to identify rare APOE variants and investigate their pathogenicity for autosomal dominant FD. We observed 24 variants in 86 unrelated probands. Most variants were unique (66.7%). Five identified APOE variants (p.Glu63ArgfsTer15, p.Gly145AlafsTer97, p.Lys164SerfsTer87, p.Arg154Cys, and p.Glu230Lys) are causal for autosomal dominant FD. One of them (p.Lys164SerfsTer87) was described for the first time. When we compared clinical data, it was found that carriers of pathogenic or likely pathogenic APOE variants had significantly higher triglyceride levels (median 5.01 mmol/L) than carriers of benign or likely benign variants (median 1.70 mmol/L, p = 0.034) and variants of uncertain significance (median 1.38 mmol/L, p = 0.036). For the first time, we estimated the expected prevalence of causal variants for autosomal dominant FD in the population sample: 0.27% (one in 619). Investigating the spectrum of APOE variants may advance our understanding of the genetic basis of FD and underscore the importance of APOE gene sequencing in patients with lipid metabolism disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Apolipoproteins EHumansFemaleMaleAdultMiddle AgedHyperlipoproteinemia Type IIIGenetic Predisposition to DiseasePrevalenceGenetic VariationAdolescentAgedMutationChildTriglyceridesYoung Adult

Stichwörter der Autor:innen

APOEapolipoprotein Eautosomal dominantdyslipidemiafamilial dysbetalipoproteinemiahyperlipoproteinemia type IIIpathogenicityphenotype/genotype correlationremnant lipoproteinstriglycerides

Substanzen

Apolipoproteins EApoE protein, humanTriglycerides

Autor:innen und Institutionen

  • National Medical Research Center for Therapy and Preventive Medicine, Ministry of Healthcare of the Russian Federation, Petroverigsky per. 10, Bld. 3, 101000 Moscow, Russia.
  • Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, 1-73, Leninskie Gory, 119991 Moscow, Russia.
  • Moscow Center for Advanced Studies, 20 Kulakova Str., 123592 Moscow, Russia.
  • Department of Natural Sciences, Novosibirsk State University, 1 Pirogova Str., 630090 Novosibirsk, Russia.
  • Institute for Artificial Intelligence, Lomonosov Moscow State University, 1-73, Leninskie Gory, 119991 Moscow, Russia.
  • All-Russia Research Institute of Agricultural Biotechnology, 127550 Moscow, Russia.

ORCID-Profile: Anastasia V Blokhina, Anna V Kiseleva, Anastasia A Zharikova, Marija Zaicenoka, Vasily E Ramensky, Elizaveta V Garbuzova, Mikhail G Divashuk, Olga A Litinskaya, Alexey N Meshkov, Oxana M Drapkina

Zitieren

APA

Blokhina, A. V., Ershova, A. I., Kiseleva, A. V., Sotnikova, E. A., Zharikova, A. A., Zaicenoka, M., Vyatkin, Y. V., Ramensky, V. E., Kutsenko, V. A., Garbuzova, E. V., Divashuk, M. G., Litinskaya, O. A., Pokrovskaya, M. S., Shalnova, S. A., Meshkov, A. N., & Drapkina, O. M. (2024). Spectrum and Prevalence of Rare APOE Variants and Their Association with Familial Dysbetalipoproteinemia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312651

Vancouver

Blokhina AV, Ershova AI, Kiseleva AV, Sotnikova EA, Zharikova AA, Zaicenoka M, et al. Spectrum and Prevalence of Rare APOE Variants and Their Association with Familial Dysbetalipoproteinemia. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312651

BibTeX
@article{Blokhina2024,
  author = {Blokhina, Anastasia V and Ershova, Alexandra I and Kiseleva, Anna V and Sotnikova, Evgeniia A and Zharikova, Anastasia A and Zaicenoka, Marija and Vyatkin, Yuri V and Ramensky, Vasily E and Kutsenko, Vladimir A and Garbuzova, Elizaveta V and Divashuk, Mikhail G and Litinskaya, Olga A and Pokrovskaya, Maria S and Shalnova, Svetlana A and Meshkov, Alexey N and Drapkina, Oxana M},
  title = {Spectrum and Prevalence of Rare APOE Variants and Their Association with Familial Dysbetalipoproteinemia},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252312651}
}
Kostenlos starten →